The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.00
Bid: 6.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 9.00 (150.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.00
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update

10 Oct 2013 07:00

RNS Number : 1559Q
Carclo plc
10 October 2013
 

10 October 2013

 

Carclo plc

("the group")

 

Half year trading update

 

The board is pleased to announce that the group has traded in line with its expectations for the first half of the financial year.

 

Conductive Inkjet Technology's ("CIT's") new Cambridge facility has been commissioned on schedule and production on its high speed coating line was validated on time. Full scale manufacture of coated film to support Atmel Corporation's ("Atmel's") start-up of the XSense™ program has commenced and CIT revenue in the first half of the financial year was approximately £1.4 million. CIT's shipments will support Atmel's previously announced ramp up of XSense™ which will see its adoption in a number of products launched across a range of tier 1 OEMs during the second half of our financial year. CIT has continued to invest in further technology developments that will support future innovation in the touch screen sector. The board remains confident that this business is on track for significant growth this financial year and into the future.

We are pleased to confirm that in its judgement issued on 7th October 2013, the English High Court has determined that CIT may pursue claims against Uni-Pixel Displays Inc ("Uni-Pixel") in the English courts for breach of confidence and patent entitlement. As a result of this successful decision, Uni-Pixel will be obliged to pay the majority of CIT's costs of this jurisdiction application.

At Carclo Diagnostic Solutions the first phase of our external review of market opportunities has indicated good suitability to a wide range of medical device sectors. The second phase of this review is underway and will assist us in identifying detailed target applications and customer opportunities. In parallel, our technical development has been focussed on performance robustness and test repeatability on both the Micropoc-pro and Micropoc-cat platforms with encouraging initial results.

In Technical Plastics profits will, as expected, be ahead of last year's comparative period. Our US business in particular has traded strongly and is set for further growth. Its capacity expansion project is on track for completion early next year. Our US and Czech businesses are both set to benefit in future years from multiple new business wins.

Reported profits in our LED Technologies division are expected to be in line with the prior year first half helped by good growth in our LED Optics business. With design wins already awarded to Wipac, the division is expected to have a much stronger second half due to the phasing of design, development and tooling projects in our Wipac LED supercar lighting business. Further project wins are anticipated for the second half as manufacturers begin to adopt Wipac's new Hyperlite LED modules.

The group's Precision Engineering division has benefitted from a good first half in its aerospace business and reported profits are expected to be comparable to last year's first half performance.

As usual, due to working days and seasonality, the group will generate a larger proportion of its operating profits in the second half of the year and this will be magnified by the projected increase in CIT coated film sales. The commercialisation of CIT and the growth prospects in Technical Plastics and LED Technologies reflect a very positive outlook for the group and the group's financial position remains strong.

The group will issue its interim results for the period to 30 September 2013 on 19 November 2013.

- ENDS -

 

 

Enquiries:

Carclo plc

01924 268040

Chris Malley, Chief Executive

Robert Brooksbank, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Stephanie Badjonat

 

Notes to editors

Carclo plc is a technology led plastics group. It is a public company whose shares are quoted on the London Stock Exchange.

 

Approximately three fifths of sales are derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

 

Approximately two fifths of sales are derived from the supply of specialised precision components to the premium automotive and aerospace industries and LED optics for a wide range of end applications. Carclo is a leader in the development of high power LED lighting for supercars.

 

Carclo's strategy is to develop new technologies and products to drive future growth. Its investment in Conductive Inkjet Technology is at the heart of the newly emerging market for very low cost printed electronics.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDIRLAIIV
Date   Source Headline
22nd Feb 202110:28 amRNSHolding(s) in Company
18th Feb 202111:19 amRNSHolding(s) in Company
12th Feb 20217:00 amRNSAppointment of Director and CFO
5th Feb 20217:00 amRNSDirector/PDMR Shareholding
4th Feb 20214:35 pmRNSPrice Monitoring Extension
4th Feb 20214:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSDirector Appointment
8th Jan 20217:00 amRNSDirector Appointment
7th Jan 202111:35 amRNSDirector/PDMR Shareholding
5th Jan 20214:40 pmRNSDirector/PDMR Shareholding
23rd Dec 20207:00 amRNSFramework Agreement
15th Dec 202010:07 amRNSAppointment of Interim CFO
27th Nov 20207:01 amRNSBoard Changes
27th Nov 20207:00 amRNSHalf Year Results
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
12th Nov 20204:33 pmRNSNotice of Interim Results
10th Nov 20204:41 pmRNSSecond Price Monitoring Extn
10th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSBoard restructure
2nd Oct 20204:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20204:36 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSAppointment of Non-Executive Chairman
29th Sep 202012:18 pmRNSResult of AGM
4th Sep 202011:04 amRNS2020 Annual Report & Accounts & Notice of 2020 AGM
25th Aug 20204:46 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSPreliminary Results for the year ended 31 March 20
18th Aug 20207:00 amRNSAppointment of NED and Chairman-elect
17th Aug 20207:00 amRNSUpdate on refinancing and current trading
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:35 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSFull Year Trading Statement and COVID-19 Update
1st May 20204:24 pmRNSHolding(s) in Company
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:37 pmRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSAppointment of Chairman
14th Apr 20202:41 pmRNSExternal Auditor Appointment
8th Apr 20202:39 pmRNSHolding(s) in Company
8th Apr 20209:03 amRNSHolding(s) in Company
6th Apr 20201:35 pmRNSHolding(s) in Company
3rd Apr 202011:40 amRNSHolding(s) in Company
30th Mar 20204:40 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSDirectorate Change
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 20204:42 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.